Patient Name : Mr.K.
VENKATA SAI Collected : 30/Apr/2023 12:11PM
Age/Gender : 21 Y 10 M 4 D /M Received : 30/Apr/2023 03:39PM
UHID/MR No : DZUH.0000000625 Reported : 30/Apr/2023 04:13PM
Visit ID : DZUHOPV2359 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PCC HUZRABAD .
IP/OP NO : Patient location : HUZRABAD,HUZRABAD
DEPARTMENT OF HAEMATOLOGY
Test Name Result Unit Bio. Ref. Range Method
COMPLETE BLOOD COUNT (CBC) , WHOLE BLOOD-EDTA
HAEMOGLOBIN 14.4 g/dL 13-17 CYANIDE FREE
COLOUROMETER
PCV 42.60 % 40-50 PULSE HEIGHT AVERAGE
RBC COUNT 4.61 Million/cu.mm 4.5-5.5 Electrical Impedence
MCV 92.4 fL 83-101 Calculated
MCH 31.1 pg 27-32 Calculated
MCHC 33.7 g/dL 31.5-34.5 Calculated
R.D.W 19.1 % 11.6-14 Calculated
TOTAL LEUCOCYTE COUNT (TLC) 5,030 cells/cu.mm 4000-10000 Electrical Impedance
DIFFERENTIAL LEUCOCYTIC COUNT (DLC)
NEUTROPHILS 62 % 40-80 Electrical Impedance
LYMPHOCYTES 30 % 20-40 Electrical Impedance
EOSINOPHILS 02 % 1-6 Electrical Impedance
MONOCYTES 06 % 2-10 Electrical Impedance
BASOPHILS 00 % <1-2 Electrical Impedance
CORRECTED TLC 5,030 Cells/cu.mm Calculated
ABSOLUTE LEUCOCYTE COUNT
NEUTROPHILS 3118.6 Cells/cu.mm 2000-7000 Electrical Impedance
LYMPHOCYTES 1509 Cells/cu.mm 1000-3000 Electrical Impedance
EOSINOPHILS 100.6 Cells/cu.mm 20-500 Electrical Impedance
MONOCYTES 301.8 Cells/cu.mm 200-1000 Electrical Impedance
PLATELET COUNT 263000 cells/cu.mm 150000-410000 IMPEDENCE/MICROSCOPY
Page 1 of 6
SIN No:HA04955989
Patient Name : Mr.K.VENKATA SAI Collected : 30/Apr/2023 12:11PM
Age/Gender : 21 Y 10 M 4 D /M Received : 30/Apr/2023 03:39PM
UHID/MR No : DZUH.0000000625 Reported : 30/Apr/2023 04:33PM
Visit ID : DZUHOPV2359 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PCC HUZRABAD .
IP/OP NO : Patient location : HUZRABAD,HUZRABAD
DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Range Method
GLUCOSE, FASTING , NAF PLASMA 101 mg/dL 70-100 GOD - POD
Comment:
As per American Diabetes Guidelines
Fasting Glucose Values in mg/d L Interpretation
<100 mg/dL Normal
100-125 mg/dL Prediabetes
≥126 mg/dL Diabetes
Page 2 of 6
Patient Name : Mr.K.VENKATA SAI Collected : 30/Apr/2023 12:11PM
Age/Gender : 21 Y 10 M 4 D /M Received : 30/Apr/2023 03:39PM
UHID/MR No : DZUH.0000000625 Reported : 30/Apr/2023 04:33PM
Visit ID : DZUHOPV2359 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PCC HUZRABAD .
IP/OP NO : Patient location : HUZRABAD,HUZRABAD
DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Range Method
GLUCOSE, POST PRANDIAL (PP), 2 149 mg/dL 70-140 GOD - POD
HOURS , NAF PLASMA
Comment:
It is recommended that FBS and PPBS should be interpreted with respect to their Biological reference ranges and not with each
other.
Conditions which may lead to lower postprandial glucose levels as compared to fasting glucose levels may be due to reactive
hypoglycemia, dietary meal content, duration or timing of sampling after food digestion and absorption, medications such as insulin
preparations, sulfonylureas, amylin analogues, or conditions such as overproduction of insulin.
Ref: Marks medical biochemistry and clinical approach
Page 3 of 6
Patient Name : Mr.K.VENKATA SAI Collected : 30/Apr/2023 12:11PM
Age/Gender : 21 Y 10 M 4 D /M Received : 30/Apr/2023 03:39PM
UHID/MR No : DZUH.0000000625 Reported : 30/Apr/2023 04:33PM
Visit ID : DZUHOPV2359 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PCC HUZRABAD .
IP/OP NO : Patient location : HUZRABAD,HUZRABAD
DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Range Method
HBA1C, GLYCATED HEMOGLOBIN , 5.4 % HPLC
WHOLE BLOOD-EDTA
ESTIMATED AVERAGE GLUCOSE (eAG) , 108 mg/dL Calculated
WHOLE BLOOD-EDTA
Comment:
Reference Range as per American Diabetes Association (ADA):
REFERENCE GROUP HBA1C IN %
NON DIABETIC ADULTS >18 YEARS <5.7
AT RISK (PREDIABETES) 5.7 – 6.4
DIAGNOSING DIABETES ≥ 6.5
DIABETICS
· EXCELLENT CONTROL 6–7
· FAIR TO GOOD CONTROL 7–8
· UNSATISFACTORY CONTROL 8 – 10
· POOR CONTROL >10
Note: Dietary preparation or fasting is not required.
1. A1C test should be performed at least two times a year in patients who are meeting treatment goals (and who have stable
glycemic control).
2. Lowering A1C to below or around 7% has been shown to reduce microvascular and neuropathic complications of type 1
and type 2 diabetes. When mean annual HbA1c is <1.1 times ULN (upper limit of normal), renal and retinal complications
are rare, but complications occur in >70% of cases when HbA1c is >1.7 times ULN.
3. Falsely low HbA1c (below 4%) may be observed in patients with clinical conditions that shorten erythrocyte life span or
decrease mean erythrocyte age. HbA1c may not accurately reflect glycemic control when clinical conditions that affect
erythrocyte survival are present. Fructosamine may be used as an alternate measurement of glycemic control
Page 4 of 6
SIN No:BI14004067,BI14004068,BI14004066
Patient Name : Mr.K.VENKATA SAI Collected : 30/Apr/2023 12:11PM
Age/Gender : 21 Y 10 M 4 D /M Received : 01/May/2023 09:47AM
UHID/MR No : DZUH.0000000625 Reported : 01/May/2023 12:43PM
Visit ID : DZUHOPV2359 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PCC HUZRABAD .
IP/OP NO : Patient location : HUZRABAD,HUZRABAD
DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Range Method
IRON STUDIES (IRON + TIBC) , SERUM
IRON 74.2 µg/dL 70-180 TPTZ
TOTAL IRON BINDING CAPACITY ( TIBC) 310 µg/dL 225 - 535 TPTZ AND NITROSO-
PSAP
% OF SATURATION 23.94 % 14-50 Calculated
Comment:
Transferrin is the primary plasma iron transport protein, which binds iron strongly at physiological pH. Transferrin is generally only
25% to 30% saturated with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC).
Diurnal variation is seen in serum iron levels—normal values in midmorning, low values in midafternoon, very low values
(approximately 10 μg/dL) near midnight.
TIBC measures the blood’s capacity to bind iron with transferrin (TRF). Estrogens and oral contraceptives increase TIBC levels.
Asparaginase, chloramphenicol, corticotropin, cortisone, and testosterone decrease the TIBC levels.
% saturation represents the amount of iron-binding sites that are occupied. Iron saturation is a better index of iron stores than
serum iron alone. % saturation is decreased in iron deficiency anemia (usually <10% in established deficiency).
Page 5 of 6
SIN No:BI14004069
This test has been performed at Apollo Health & Lifestyle Ltd, Global Reference Laboratory,Hyderabad
Patient Name : Mr.K.VENKATA SAI Collected : 30/Apr/2023 12:11PM
Age/Gender : 21 Y 10 M 4 D /M Received : 30/Apr/2023 03:39PM
UHID/MR No : DZUH.0000000625 Reported : 30/Apr/2023 04:25PM
Visit ID : DZUHOPV2359 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PCC HUZRABAD .
IP/OP NO : Patient location : HUZRABAD,HUZRABAD
DEPARTMENT OF IMMUNOLOGY
Test Name Result Unit Bio. Ref. Range Method
THYROID PROFILE (TOTAL T3, TOTAL T4, TSH) , SERUM
TRI-IODOTHYRONINE (T3, TOTAL) 1.2 ng/mL 0.8-2.0 ECLIA
THYROXINE (T4, TOTAL) 8.26 µg/dL 5.1-14.1 ECLIA
THYROID STIMULATING HORMONE 7.720 uIU/mL 0.27-4.2 ECLIA
(TSH)
Comment:
Serum TSH concentrations exhibit a diurnal variation with the peak occurring during the night and the nadir occurring between
10 a.m. and 4 p.m.In primary hypothyroidism, thyroid-stimulating hormone (TSH) levels will be elevated. In primary
hyperthyroidism,TSH levels will be low. Elevated or low TSH in the context of normal free thyroxine is often referred to as
subclinical hypo- or hyperthyroid-ism, respectively. Physiological rise in Total T3 / T4 levels is seen in pregnancy and in patients on
steroid therapy.
Recommended test for T3 and T4 is unbound fraction or free levels as it is metabolically active.
Note:
Bio Ref Range for TSH in uIU/ml (As per
For pregnant females
American Thyroid Association)
First trimester 0.1 - 2.5
Second trimester 0.2 – 3.0
Third trimester 0.3 – 3.0
*** End Of Report ***
Page 6 of 6
SIN No:IM05396505
